Company / Operating Income
Whitehawk Therapeutics, Inc. Operating Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$67.5M
FY2025
5-year range
-$111.2M / -$2.5M
FY2021-FY2025
Trend
+6.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income has fluctuated over the past 8 years, ranging from -$111M in FY2022 to -$3M in FY2021.
Based on SEC 10-K filings.
-$67M in FY2025.
Declined from -$63M to -$67M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income increased 6.2% year-over-year.
- Peak operating income was recorded in FY2021.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$67.5M | +6.2% |
| FY2024 | -$71.9M | -14.8% |
| FY2023 | -$62.7M | +43.6% |
| FY2022 | -$111.2M | -4263.2% |
| FY2021 | -$2.5M | +89.6% |
| FY2020 | -$24.4M | -118.6% |
| FY2019 | -$11.2M | +47.7% |
| FY2018 | -$21.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026